Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
J. C. L. Erve, S. C. Vashishtha, O. Ojewoye, A. Adedoyin, R. Espina, W. DeMaio & R. E. Talaat. (2008) Metabolism of prazosin in rat and characterization of metabolites in plasma, urine, faeces, brain and bile using liquid chromatography/mass spectrometry (LC/MS). Xenobiotica 38:5, pages 540-558.
Read now
Read now
A. L. Servin, D. Wicek, M. P. Oryszczyn, C. Jacquot, J. P. Lussiana, H. Christinaki & C. Viel. (1987) Metabolism of 6,7-dimethoxy 4-(4′-chlorobenzyl)isoquinoline. II. Role of liver catechol O-methyltransferase and glutathione. Xenobiotica 17:12, pages 1381-1391.
Read now
Read now
J. M. Le Fur & J. P. Labaune. (1985) Metabolic pathway by cleavage of a furan ring. Xenobiotica 15:7, pages 567-577.
Read now
Read now
A. L. Servin, C. Jacquot, J. P. Lussiana & C. Viel. (1985) Metabolism of 6,7-dimethoxy 4-(p-chlorobenzyl)-isoquinoline. I. Single-dose pharmacokinetics in the rat and mouse. Xenobiotica 15:7, pages 553-566.
Read now
Read now
C. Yamato, T. Takahashi, K. Kinoshita & T. Fujita. (1982) The metabolic fate of 4-amino-2-(4-butanoyl-hexahydro-1H-1, 4-diazepin-1-y1)-6, 7-dimethoxy-quinazoline HCI. Xenobiotica 12:9, pages 549-559.
Read now
Read now
A. G. Roach, F. Lefèvre & I. Cavero. (1978) Effects of Prazosin and Phentolamine on Cardiac Presynaptic α-Adrenoceptors in the Cat, Dog and Rat. Clinical and Experimental Hypertension 1:1, pages 87-101.
Read now
Read now
Articles from other publishers (67)
Derviş GÖK. (2022) An Efficient One-Pot Three-Component Synthesis of Novel Quinazoline-4-Carboxylic Acid and Its Ester and Amide DerivativesBir Etkili Tek Ortamda Üç Bileşenli Yeni Kinazolin-4-Karboksilik Asit ve Onun Ester ve Amit Türevlerinin Sentezi. Hacettepe Journal of Biology and Chemistry 50:4, pages 377-386.
Crossref
Crossref
Heather D. Snell, Ariel VitenzonEsra TaraChris Chen, Jaafar Tindi, Bryen A. JordanKamran Khodakhah. (2022) Mechanism of stress-induced attacks in an episodic neurologic disorder. Science Advances 8:16.
Crossref
Crossref
Gregory S. Carter. 2022. Sleep Medicine and the Evolution of Contemporary Sleep Pharmacotherapy. Sleep Medicine and the Evolution of Contemporary Sleep Pharmacotherapy.
Nadia O. Bamfo, Chelsea Hosey-Cojocari, Leslie Z. Benet & Connie M. Remsberg. (2021) Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans. Pharmaceutical Research 38:7, pages 1139-1156.
Crossref
Crossref
Elizabeth K. Lucas, Wan-Chen Wu, Ciorana Roman-Ortiz & Roger L. Clem. (2018) Prazosin during fear conditioning facilitates subsequent extinction in male C57Bl/6N mice. Psychopharmacology 236:1, pages 273-279.
Crossref
Crossref
Sachin A. Sarode, Vilas G. Jadhav & Jayashree M. Nagarkar. (2017) Synthesis of 2-aryl quinazolines from (2-aminophenyl)methanol and oxime ether catalyzed by copper ferrite nanoparticles. Tetrahedron Letters 58:8, pages 779-784.
Crossref
Crossref
André O. White & Anthony S. Rauhut. (2014) Time-dependent effects of prazosin on the development of methamphetamine conditioned hyperactivity and context-specific sensitization in mice. Behavioural Brain Research 263, pages 80-89.
Crossref
Crossref
Ke Liu. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
4
.
Manabu Takita, Takanobu Taniguchi, Jun Zhu & Ikunobu Muramatsu. (1997) Chronic Treatment with Prazosin Causes a Subtype-specific Increase in the α1-Adrenoceptor Density of the Stressed Rat Cerebral Cortex. Journal of Pharmacy and Pharmacology 49:8, pages 802-805.
Crossref
Crossref
Janie Chiang, Görel Hermodsson & Svein Øie. (1991) The Effect of α1-Acid Glycoprotein on the Pharmacological Activity of α1-Adrenergic Antagonists in Rabbit Aortic Strips. Journal of Pharmacy and Pharmacology 43:8, pages 540-547.
Crossref
Crossref
R AchariA H Beckett. (1983) In-vitro metabolism of two mono-substituted piperazines using liver homogenates of rats and rabbits. Journal of Pharmacy and Pharmacology 35:9, pages 615-616.
Crossref
Crossref
John C. L. Erve, William DeMaio & Rasmy E. Talaat. (2008) Rapid metabolite identification with sub parts-per-million mass accuracy from biological matrices by direct infusion nanoelectrospray ionization after clean-up on a ZipTip and LTQ/Orbitrap mass spectrometry. Rapid Communications in Mass Spectrometry 22:19, pages 3015-3026.
Crossref
Crossref
Yu-Chun Liu, Hai-Yan Liu, Hui-Wen Yang, Tao Wen, Yang Shang, Xiao-Dong Liu, Lin Xie & Guang-Ji Wang. (2007) Impaired expression and function of breast cancer resistance protein (Bcrp) in brain cortex of streptozocin-induced diabetic rats. Biochemical Pharmacology 74:12, pages 1766-1772.
Crossref
Crossref
John C. L. Erve, Sarvesh C. Vashishtha, William DeMaio & Rasmy E. Talaat. (2007) Metabolism of Prazosin in Rat, Dog, and Human Liver Microsomes and Cryopreserved Rat and Human Hepatocytes and Characterization of Metabolites by Liquid Chromatography/Tandem Mass Spectrometry. Drug Metabolism and Disposition 35:6, pages 908-916.
Crossref
Crossref
Csaba Wéber, Attila Bielik, Ádám Demeter, István Borza, Györgyi I. Szendrei, György M. Keserű & István Greiner. (2005) Solid-phase synthesis of 6-hydroxy-2,4-diaminoquinazolines. Tetrahedron 61:39, pages 9375-9380.
Crossref
Crossref
Eric A Stone, Yan Lin, Helen Rosengarten, H Kenneth Kramer & David Quartermain. (2003) Emerging Evidence for a Central Epinephrine-Innervated α1-Adrenergic System that Regulates Behavioral Activation and is Impaired in Depression. Neuropsychopharmacology 28:8, pages 1387-1399.
Crossref
Crossref
Yuan H Zhao, Michael H Abraham, Joelle Le, Anne Hersey, Chris N Luscombe, Gordon Beck, Brad Sherborne & Ian Cooper. (2003) Evaluation of rat intestinal absorption data and correlation with human intestinal absorption. European Journal of Medicinal Chemistry 38:3, pages 233-243.
Crossref
Crossref
Fatih M. Uckun, Jason Thoen, Hao Chen, Elise Sudbeck, Chen Mao, Ravi Malaviya, Xing-Ping Liu & Chun-Lin Chen. (2002)
CYP1A-Mediated Metabolism of the Janus Kinase-3 Inhibitor 4-(4′-Hydroxyphenyl)-amino-6,7-dimethoxyquinazoline: Structural Basis for Inactivation by Regioselective
O
-Demethylation
. Drug Metabolism and Disposition 30:1, pages 74-85.
Crossref
Crossref
Andre S. Pupo & Kenneth P. Minneman. (2014) Adrenergic Pharmacology: Focus on the Central Nervous System. CNS Spectrums 6:8, pages 656-662.
Crossref
Crossref
Eric A Stone, Helen Rosengarten, Yan Lin & David Quartermain. (2001) Pharmacological blockade of brain α1-adrenoceptors as measured by ex vivo [3H]prazosin binding is correlated with behavioral immobility. European Journal of Pharmacology 420:2-3, pages 97-102.
Crossref
Crossref
Alexander Scriabine & David G. Taylor. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
E.A. Stone, Y. Zhang, H. Rosengarten, J. Yeretsian & D. Quartermain. (1999) Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 94:4, pages 1245-1252.
Crossref
Crossref
Eric A Stone & David Quartermain. (1999) Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biological Psychiatry 46:9, pages 1287-1300.
Crossref
Crossref
S.M. Khedun, J. Moodley, T. Naicker & B. Maharaj. (1997) Drug management of hypertensive disorders of pregnancy. Pharmacology & Therapeutics 74:2, pages 221-258.
Crossref
Crossref
R. Rossi & E. Scharrer. (1994) Inhibitory effect of the α1-adrenergic antagonist prazosin on food intake in pygmy goats. Pharmacology Biochemistry and Behavior 47:4, pages 851-856.
Crossref
Crossref
Joseph Rochford, Patricia Dawes & Jane Stewart. (1993) Naloxone potentiation of novelty-induced hypoalgesia: Characterization of the α-noradrenergic receptor subtype. Pharmacology Biochemistry and Behavior 44:2, pages 381-386.
Crossref
Crossref
Z. Szreder & Z. Korolkiewicz. (1991) Inhibition of pyrogen Escherichia coli fever with intracerebral administration of prazosin, dihydrobenzperidol and nifedipin in the rabbits. General Pharmacology: The Vascular System 22:2, pages 381-388.
Crossref
Crossref
Günter SeyffartGünter Seyffart. 1991. Drug Dosage in Renal Insufficiency. Drug Dosage in Renal Insufficiency
443
515
.
P. J. M. Guelen, T. J. Janssen, M. H. Lam, T. B. Vree & P. S. Exler. (1990) Comparative bioavailability study of two brands of prazosin-containing tablets in healthy volunteers. Pharmaceutisch Weekblad Scientific Edition 12:5, pages 184-187.
Crossref
Crossref
Leonard J. Kostek. 1990.
351
378
.
P. A. van Zwieten. 1990. Pharmacology of Antihypertensive Therapeutics. Pharmacology of Antihypertensive Therapeutics
105
129
.
Richard E. Tessel. (2008) Noradrenergic processes in the behavioral actions of psychomotor stimulants. Drug Development Research 20:3, pages 359-368.
Crossref
Crossref
Margaret D. Brown. (1989) Myocardial chronotropic and inotropic responsiveness in vitro after chronic α-adrenoreceptor blockade in the rat. Journal of Autonomic Pharmacology 9:6, pages 387-395.
Crossref
Crossref
Margaret D. Brown. (1989) Myocardial chronotropic and inotropic responsiveness in vitro after chronic α-adrenoreceptor blockade in the rat. Journal of Autonomic Pharmacology 9:6, pages 387-395.
Crossref
Crossref
Amar Ziada, O. Hudlicka & K. R. Tyler. (1989) The effect of long-term administration of ?1-blocker prazosin on capillary density in cardiac and skeletal muscle. Pfl�gers Archiv European Journal of Physiology 415:3, pages 355-360.
Crossref
Crossref
J. E. Humphreys & M. A. Waite. (1989) ALPHA-1 BLOCKERS. A NEW GENERATION OF ANTIHYPERTENSIVE AGENTS. Journal of Clinical Pharmacy and Therapeutics 14:4, pages 263-283.
Crossref
Crossref
MS Lennard, JC McGourty & JH Silas. (2012) Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics and first dose effect of prazosin.. British Journal of Clinical Pharmacology 25:2, pages 276-278.
Crossref
Crossref
V. K. Piotrovskii, N. N. Veiko, I. V. Golovanova, T. A. Gus'kova, M. K. Polievktov, V. I. Metelitsa, L. N. Yakhontov & V. A. Azimov. (1987) Delayed elimination of a prazosin metabolite compared with kinetics of prazosin injected intravenously into rabbits. Bulletin of Experimental Biology and Medicine 103:1, pages 85-87.
Crossref
Crossref
Adam Schneeweiss & Gotthard SchettlerAdam Schneeweiss & Gotthard Schettler. 1987. Cardiovascular Drug Therapy in the Elderly. Cardiovascular Drug Therapy in the Elderly
145
155
.
Alan D. Dauer. (1986) Terazosin: An effective once-daily monotherapy for the treatment of hypertension. The American Journal of Medicine 80:5, pages 29-34.
Crossref
Crossref
Robert C. Sonders. (1986) Pharmacokinetics of terazosin. The American Journal of Medicine 80:5, pages 20-24.
Crossref
Crossref
B Kaye, NJ Cussans, JK Faulkner, DA Stopher & JL Reid. (2012) The metabolism and kinetics of doxazosin in man, mouse, rat and dog.. British Journal of Clinical Pharmacology 21:S1.
Crossref
Crossref
L. Leinonen & D. Stenberg. (1986) Sleep in Macaca arctoides and the effects of prazosin. Physiology & Behavior 37:2, pages 199-202.
Crossref
Crossref
Wulf-Dirk BussmannWulf-Dirk Bussmann. 1986. Acute and Chronic Heart Failure. Acute and Chronic Heart Failure
235
251
.
M. D. Mashkovskii, B. A. Medvedev & V. A. Parshin. (1985) Pharmacological properties and therapeutic use of a new antihypertensive preparation, prazosin. Pharmaceutical Chemistry Journal 19:10, pages 727-729.
Crossref
Crossref
ILKKA HILAKIVI & ANTERO LEPPÄVUORI. (2008) Effects of methoxamine, an alpha‐1 adrenoceptor agonist, and prazosin, an alpha‐1 antagonist, on the stages of the sleep—waking cycle in the cat. Acta Physiologica Scandinavica 120:3, pages 363-372.
Crossref
Crossref
P.B.M.W.M. Timmermans & P.A. van Zwieten. 1984. Pharmacology of Antihypertensive Drugs. Pharmacology of Antihypertensive Drugs
239
248
.
V. K. Piotrovskii, N. N. Veiko, O. S. Ryabokon, S. F. Postolnikov & V. I. Metelitsa. (1984) Identification of a prazosin metabolite and some preliminary data on its kinetics in hypertensive patients. European Journal of Clinical Pharmacology 27:3, pages 275-280.
Crossref
Crossref
W.-D. Bussmann. 1984. Herzinsuffizienz. Herzinsuffizienz
657
718
.
J. Allen. (2006)
A synthesis of [
14
C]alfuzosine hydrochloride
. Journal of Labelled Compounds and Radiopharmaceuticals 20:11, pages 1283-1286.
Crossref
Crossref
Ilkka Hilakivi. (1983) The role of β- and α-adrenoceptors in the regulation of the stages of the sleep-waking cycle in the cat. Brain Research 277:1, pages 109-118.
Crossref
Crossref
Michael R. Dashwood. (1982) Central and peripheral prazosin binding: An in vitro autoradioraphic study in the rat. European Journal of Pharmacology 86:1, pages 51-58.
Crossref
Crossref
Peter Seideman. (2009) Pharmacokinetic and dynamic aspects of α–adrenoceptor blockade in hypertension. Acta Medica Scandinavica 212:S665, pages 61-66.
Crossref
Crossref
David B. Menkes, Jay M. Baraban & George K. Aghajanian. (1981) Prazosin selectively antagonizes neuronal responses mediated by ?1-adrenoceptors in brain. Naunyn-Schmiedeberg's Archives of Pharmacology 317:3, pages 273-275.
Crossref
Crossref
H. W. Wetzel, M. S. Briley & S. Z. Langer. (1981) 3H-WB 4101 binding in the rat vas deferens. Naunyn-Schmiedeberg's Archives of Pharmacology 317:3, pages 187-192.
Crossref
Crossref
PC Rubin, PJ Scott & JL Reid. (2012) Prazosin disposition in young and elderly subjects.. British Journal of Clinical Pharmacology 12:3, pages 401-404.
Crossref
Crossref
B. N. C. Prichard, C. W. I. Owens & J. Tuckman. 1981. Adrenergic Activators and Inhibitors. Adrenergic Activators and Inhibitors
559
697
.
A. J. Smith & G. T. Tucker. 1981. Adrenergic Activators and Inhibitors. Adrenergic Activators and Inhibitors
417
504
.
Icilio Cavero & Alan G. Roach. (1980) The pharmacology of prazosin, a novel antihypertensive agent. Life Sciences 27:17, pages 1525-1540.
Crossref
Crossref
P Rubin, G Jackson & T Blaschke. (2012) Studies on the clinical pharmacology of prazosin. II: The influence of indomethacin and of propranolol on the action and disposition of prazosin.. British Journal of Clinical Pharmacology 10:1, pages 33-39.
Crossref
Crossref
PC Rubin & TF Blaschke. (2012) Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.. British Journal of Clinical Pharmacology 10:1, pages 23-32.
Crossref
Crossref
Jan Koch-Weser, Robert M. Graham & William A. Pettinger. (1979) Prazosin. New England Journal of Medicine 300:5, pages 232-236.
Crossref
Crossref
D. N. Bateman, D. C. Hobbs, T. M. Twomey, E. A. Stevens & M. D. Rawlins. (1979) Prazosin, pharmacokinetics and concentration effect. European Journal of Clinical Pharmacology 16:3, pages 177-181.
Crossref
Crossref
R. N. Brogden, R. C. Heel, T. M. Speight & G. S. Avery. 1979. Antihypertensive Drugs Today. Antihypertensive Drugs Today
125
169
.
DONALD C. HOBBS, THOMAS M. TWOMEY & ROGER F. PALMER. (1978) Pharmacokinetics of Prazosin in Man. The Journal of Clinical Pharmacology 18:8-9, pages 402-406.
Crossref
Crossref
Alan G. Roach, Roberto Gomeni, Mervyn Mitchard, Jean-Paul Nicolas & Icilio Cavero. (1978) The blood pressure lowering effects of intravenous versus intracerebroventricular prazosin in anaesthetised cats. European Journal of Pharmacology 49:3, pages 271-278.
Crossref
Crossref
W. Lesley Matier & William T. Comer. 1978.
71
81
.